Hold: Unanimous consensus preserves franchise exposure without adding at stretched $357 entry; tiered entry framework and $335 stop defined
Hold is the disciplined synthesis that respects unanimous analyst consensus, the 8/6 anti-trim lesson at franchise-quality names, the 8/5 franchise-quality anti-exit argument, the 8/12 hedge-or-substitute lesson on compressing-multiple regime lag, the 8/14 lesson that hedge-required theses label Hold not Overweight, and the empirical pattern of pre-earnings directional bets bleeding alpha at this exact setup. The Aggressive Analyst is correct that underweighting a 17.8% ROE compounder with $13B/quarter capital return is the bigger long-term risk; the Conservative Analyst is correct that the technical setup at $357 is fragile and R/R is capped at ~1:1; the Neutral Analyst is correct that tiered entry with dry powder is the correct risk allocation. Maintain exposure at current weight; use defined triggers: $335 hard stop, $342-346 primary add zone with reversal confirmation, $365-367 trim zone on retest without catalysts, retained December $340 put hedge, tiered add framework (25% tranches at $355-357/$342-346/$330-335/plus confirmation reserve), and Q3 2026 earnings mid-October as mandatory reassessment gate.
| Position | Action |
|---|---|
| Current price $357 | Do NOT add; risk/reward capped at ~1:1 (bear fair value $352.50 below spot) |
| Tranche 1: Price $355-357 + 10 EMA reclaim + RSI >60 | Add 25% of intended expansion (capped at 0.5x original position size) |
| Tranche 2: Price $342-346 (50 SMA zone $340.87) + bullish reversal candle | Add 25% of intended expansion (capped at 0.5x original position size) |
| Tranche 3: Price $330-335 + macro deterioration (2s10s un-inversion, dovish Fed surprise, recession confirmation) | Add 25% of intended expansion (capped at 0.5x original position size) |
| Tranche 4: Confirmed MACD histogram positive cross + daily close >$366.50 on volume >7M | Reserve 25% for full Overweight deployment on technical confirmation |
| Price retests $365-367 (Bollinger upper band/prior high) without fresh catalysts | Trim 10-20% of position into strength (1T milestone likely sell-the-news) |
| Daily close below $312.81 (200 SMA) on rising volume | Full exit; structural trend break confirmed |
JPM is a BUY — the world's most profitable bank approaching a historic $1 trillion market cap milestone, trading at a modest 14.3x forward earnings discount, with accelerating NII, 17.8% ROE, aggressive capital returns, and macro tailwinds from higher-for-longer rates.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | 313.38 | bullish |
| 50 SMA | 341.82 | bullish |
| 10 EMA | 359.90 | bearish |
| RSI (14) | 55.52 | bearish |
| MACD | 5.97 | bearish |
| MACD Signal | 6.81 | bearish |
| MACD Histogram | -0.83 | bearish |
| Bollinger Middle (20-SMA) | 357.08 | neutral |
| Bollinger Upper Band | 367.67 | neutral |
| Bollinger Lower Band | 346.49 | bullish |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price $355-357 + 10 EMA reclaim ($360) + RSI >60 + MACD histogram turning positive
Then: Add 25% of intended expansion (max 0.5x original position)
NII is structurally accelerating with 53% growth over four years driven by repricing of the entire asset base into a higher-rate world, with loans hitting $1.52T.
EV: +12% ($400-$420 target vs $357 current) · concedes: Dimon succession risk is valid — but he has been signaling this for years and the market has had time to price it; the franchise has institutional depth; Credit cycle / CRE / delinquencies are sector watch items — though JPM's card book quality has been better than peers with 8% recession probability; Goldman escalating in AWM with the LCN deal is real — but this forces JPM to push harder in the highest-multiple revenue stream and they have the talent, tech spend, and global footprint to respond; Bear's 'wait for $315' entry zone is fine for them — I'll collect compounding while certainty catches up
JPM is a high-quality franchise at a cyclical-peak multiple, with trend-exhaustion signals across four independent momentum indicators, in a macro environment where consensus is dangerously one-sided and tail risks are materially underpriced.
EV: $352.50 (probability-weighted); current price $357 · concedes: JPM is a high-quality franchise with strong institutional depth; Dimon has built a durable competitive moat over 20 years; 17.8% ROE is genuinely above average; Aggressive buyback program has been executed consistently; Regulatory easing is a legitimate potential tailwind; Fair value DCF estimate of ~$346 (3% below current price) is directionally reasonable
→ vs conservative: ATR compression from $7.94 to $6.20 does not indicate direction—the conservative analyst is guessing; in positive momentum with structural buybacks, the directional move skews UP
→ vs conservative: Risk/reward of 1:1 uses wrong distribution—probability-weighted scenarios yield expected value meaningfully above $352.50; conservative overweights tail risk and underweights base case
→ vs neutral: HOLD is too passive; waiting for $342 entry ignores that 50 SMA rises ~50 cents/day, making that entry level likely $350+ by the time JPM retraces
→ vs neutral: Bear fair value of $352.50 is $50 too low; it uses yesterday's earnings power for tomorrow's price and discounts the compounder to value the noise
→ vs conservative: JPM is a 0.98 beta utility-like compounder, not a high-beta speculative name—the wrong volatility profile is being used to justify sitting out
→ vs neutral: Full exposure should be maintained and ADD on first 10 EMA reclaim above $360, not wait for a $342 entry the rising trend will likely never deliver
→ vs conservative: Dimon succession has been 'imminent' for five years; market has priced the discount—transition will be either non-event or buying opportunity, not a reason to avoid owning the stock
| 6.20 |
| neutral |
| Close | 357.26 | neutral |
Support: 346.49 · 341.82 · 313.38 | Resistance: 359.9 · 366.5 · 367.67
JPM technical analysis shows conflicting signals: long-term trend remains decisively bullish (200 SMA rising, price +13.95% above at $313.38), but short-term momentum has shifted bearish with the close breaking below the 10 EMA ($359.90), MACD bearish crossover (line 5.97 below signal 6.81), MACD histogram negative and expanding to −0.83, and RSI cooling from overbought 71 to 55. ATR compression of ~22% in one month suggests an imminent directional move. Current transaction proposal is HOLD—the setup favors patience over aggression with key support at $346.49 (BB lower) and $341.82 (50 SMA), and resistance at $359.90 (10 EMA) and $367.67 (BB upper).
Market Cap
$949.66 B
Trailing P/E
15.29x
Forward P/E
14.29x
PEG Ratio
1.77
Price / Book
2.69x
Book Value / Share
$133.01
Beta (5y)
0.977
52-Week High
$366.50
52-Week Low
$279.10
50-Day MA
$341.39
200-Day MA
$315.42
TTM Revenue
$186.33 B
TTM Net Income
$63.63 B
TTM EPS
$23.36
Forward EPS
$25.01
Profit Margin
34.9%
Operating Margin
50.4%
Return on Equity (ROE)
17.8%
Return on Assets (ROA)
1.36%
Revenue 2022
$127.7 B
Revenue 2023
$155.0 B
Revenue 2024
$169.4 B
Revenue 2025
$181.8 B
Net Income 2022
$37.7 B
Net Income 2023
$49.6 B
Net Income 2024
$58.5 B
Net Income 2025
$57.0 B
Diluted EPS 2022
$12.09
Diluted EPS 2023
$16.23
Diluted EPS 2024
$19.75
Diluted EPS 2025
$20.02
Net Interest Income (NII) 2022
$66.7 B
Net Interest Income (NII) 2023
$89.3 B
Net Interest Income (NII) 2024
$92.6 B
Net Interest Income (NII) 2025
$95.4 B
Q2 2026 NII
$25.5 B
Q2 2026 Revenue
$52.85 B
Q2 2026 Net Income
$21.16 B
Q2 2026 EPS
$7.70
Q2 2026 Pretax Income
$27.52 B
Q2 2026 Operating Expenses
$16.83 B
Q2 2026 Tax Provision
$6.36 B
Total Assets Q2 2026
$5,015 B
Net Loans Q2 2026
$1,516 B
Investments & Advances Q2 2026
$1,587 B
Trading Securities Q2 2026
$794 B
Cash & Equivalents Q2 2026
$310 B
Total Equity Q2 2026
$375 B
Tangible Book Value Q2 2026
$289 B
Total Debt Q2 2026
$533 B
Goodwill & Intangibles
$64 B
Retained Earnings Q2 2026
$445 B
Treasury Stock Q2 2026
$178 B
Buybacks 2025
$34.6 B
Dividends Paid 2025
$16.6 B
Total Shareholder Returns 2025
~$51 B
Diluted Shares 2022
~2.97 B
Diluted Shares Q2 2026
~2.69 B
Cash + Fed Funds Sold
$756 B
Distance to 52W High
~2.5%
Revenue Growth 5Y CAGR
~12%
EPS Growth 2022 to TTM
~93%
Goodwill / Equity
17.2%
Strengths
Concerns
JPMorgan Chase & Co. (JPM) is the largest U.S. bank holding company with $5.02T in assets, operating across Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking, and Asset & Wealth Management segments. The bank delivered exceptional Q2 2026 results with $21.16B net income and $7.70 EPS, though the print included ~$4.4B in non-recurring items. TTM fundamentals show $186.3B revenue and $63.6B net income, translating to industry-leading 17.8% ROE and 34.9% profit margins. The fortress balance sheet supports $51B in annual capital returns (90% payout ratio), with buybacks reducing share count by 9.5% since 2022. Trading at $357 (~2.5% below 52-week high of $366.50), the stock commands a 14.29x forward P/E and 2.69x P/B—reasonable but not cheap relative to historical ranges. Analyst positioning: HOLD for existing holders; accumulate on pullbacks toward $315 (200-day MA) with 12-month target of $400-$420.
Macro: Fed on hold: Polymarket prices 85% probability of zero Fed rate cuts in 2026 ($7.3M volume), with July FOMC minutes showing most participants supported holding steady; bond traders hedging potential 2027 cuts. Treasury expanded long-bond buybacks to lower long-end yields, producing a bull-flattener. Soft landing probability at 63% (up +8.5pp WoW) with recession risk at 8% (down -0.5pp WoW). Inflation >5% probability at 8% and >4.5% at 12%, both trending down. Oil extending gains due to Strait of Hormuz standoff with no diplomatic progress; Japan recession probability at 31% (up +3pp WoW). Disinflationary drift supports hold-rate regime, which is a structural NII tailwind for JPM.